Pruritus in cutaneous T-cell lymphoma: A review

Journal of the American Academy of Dermatology

Volumn 67, Issue 4, 2012, Pages 760-768

  Ahern, Kristen ^a   Gilmore, Elaine S ^a   Poligone, Brian ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

cutaneous T cell lymphoma; mycosis fungoides; pathophysiology; pruritus; S zary syndrome; therapy

Indexed keywords

ALEMTUZUMAB; ANTIHISTAMINIC AGENT; APREPITANT; BUTORPHANOL; CARMUSTINE; CHLORMETHINE; CORTICOSTEROID; CYCLOSPORIN A; CYTOKINE; GABAPENTIN; GASTRIN RELEASING PEPTIDE; GASTRIN RELEASING PEPTIDE RECEPTOR; HISTAMINE H4 RECEPTOR ANTAGONIST; METHOXSALEN; MIRTAZAPINE; NALOXONE; NALTREXONE; OPIATE; PROTEINASE; PSORALEN; RETINOID; SUBSTANCE P; THALIDOMIDE; VORINOSTAT;

ATOPIC DERMATITIS; BEDTIME DOSAGE; CHOLESTASIS; CHRONIC URTICARIA; CUTANEOUS T CELL LYMPHOMA; DISEASE ASSOCIATION; DRUG MECHANISM; EXTRACORPOREAL PHOTOPHERESIS; HUMAN; MEDICAL LITERATURE; MEDLINE; MYCOSIS FUNGOIDES; NONHUMAN; PEER REVIEW; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; PUVA; REVIEW; SEZARY SYNDROME; SPINAL GANGLION; SYSTEMATIC REVIEW;

HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; PRURITUS; SKIN NEOPLASMS;

EID: 84866379888     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.12.021     Document Type: Review

References (83)

1. S. Rothman Physiology of itching Physiol Rev 21 1941 357 381
2. O. Dereure, and J.J. Guilhou Invisible mycosis fungoides: a new case J Am Acad Dermatol 45 2001 318 319
3. R.M. Pujol, F. Gallardo, E. Llistosella, A. Blanco, L. Bernado, and R. Bordes Invisible mycosis fungoides: a diagnostic challenge J Am Acad Dermatol 47 Suppl 2002 S168 S171
4. R. Willemze, E.S. Jaffe, G. Burg, L. Cerroni, E. Berti, and S.H. Swerdlow WHO-EORTC classification for cutaneous lymphomas Blood 105 2005 3768 3785
5. R.K. Winkelmann, and W.A. Caro Current problems in mycosis fungoides and Sézary syndrome Annu Rev Med 28 1977 251 269
6. F. Sampogna, M. Frontani, G. Baliva, G.A. Lombardo, G. Alvetreti, and C. Di Pietro Quality of life and psychological distress in patients with cutaneous lymphoma Br J Dermatol 160 2009 815 822
7. S.B. Green, D.P. Byar, and S.I. Lamberg Prognostic variables in mycosis fungoides Cancer 47 1981 2671 2677
8. P. Gerami, S. Rosen, T. Kuzel, S.L. Boone, and J. Guitart Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma Arch Dermatol 144 2008 738 746
9. M. Schmelz, R. Schmidt, A. Bickel, H.O. Handwerker, and H.E. Torebjork Specific C-receptors for itch in human skin J Neurosci 17 1997 8003 8008
10. H.O. Handwerker Microneurography of pruritus Neurosci Lett 470 2010 193 196
11. D. Andrew, and A.D. Craig Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch Nat Neurosci 4 2001 72 77
12. R. Dummer, P.W. Heald, F.O. Nestle, E. Ludwig, E. Laine, and S. Hemmi Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain) Blood 88 1996 1383 1389
13. R. Dummer, O. Kohl, J. Gillessen, M. Kagi, and G. Burg Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma: reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation Arch Dermatol 129 1993 433 436
14. B.R. Vowels, M. Cassin, E.C. Vonderheid, and A.H. Rook Aberrant cytokine production by Sézary syndrome patients: cytokine secretion pattern resembles murine Th2 cells J Invest Dermatol 99 1992 90 94
15. E. Papadavid, J. Economidou, A. Psarra, V. Kapsimali, V. Mantzana, and C. Antoniou The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome Br J Dermatol 148 2003 709 718
16. E.A. Sausville, J.L. Eddy, R.W. Makuch, A.B. Fischmann, G.P. Schechter, and M. Matthews Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome: definition of three distinctive prognostic groups Ann Intern Med 109 1988 372 382
17. M.A. Ionescu, J. Rivet, M. Daneshpouy, J. Briere, P. Morel, and A. Janin In situ eosinophil activation in 26 primary cutaneous T-cell lymphomas with blood eosinophilia J Am Acad Dermatol 52 2005 32 39
18. T.H. Totterman, A. Scheynius, A. Killander, A. Danersund, and G.V. Alm Treatment of therapy-resistant Sézary syndrome with cyclosporin-A: suppression of pruritus, leukemic T cell activation markers and tumor mass Scand J Haematol 34 1985 196 203
19. S. Ho, N. Clipstone, L. Timmermann, J. Northrop, I. Graef, and D. Fiorentino The mechanism of action of cyclosporin A and FK506 Clin Immunol Immunopathol 80 1996 S40 S45
20. L.S. Chan, N. Robinson, and L. Xu Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis J Invest Dermatol 117 2001 977 983
21. S. Wenzel, D. Wilbraham, R. Fuller, E.B. Getz, and M. Longphre Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies Lancet 370 2007 1422 1431
22. S.R. Dillon, C. Sprecher, A. Hammond, J. Bilsborough, M. Rosenfeld-Franklin, and S.R. Presnell Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice Nat Immunol 5 2004 752 760
23. S. Kasraie, M. Niebuhr, and T. Werfel Interleukin (IL)-31 induces pro-inflammatory cytokines in human monocytes and macrophages following stimulation with staphylococcal exotoxins Allergy 65 2010 712 721
24. T. Bando, Y. Morikawa, T. Komori, and E. Senba Complete overlap of interleukin-31 receptor A and oncostatin M receptor beta in the adult dorsal root ganglia with distinct developmental expression patterns Neuroscience 142 2006 1263 1271
25. R. Gutzmer, S. Mommert, M. Gschwandtner, K. Zwingmann, H. Stark, and T. Werfel The histamine H4 receptor is functionally expressed on T(H)2 cells J Allergy Clin Immunol 123 2009 619 625
26. J.M. Cowden, M. Zhang, P.J. Dunford, and R.L. Thurmond The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation J Invest Dermatol 130 2010 1023 1033
27. E.E. Carstens, M.I. Carstens, C.T. Simons, and S.L. Jinks Dorsal horn neurons expressing NK-1 receptors mediate scratching in rats Neuroreport 21 2010 303 308
28. S.E. Chang, S.S. Han, H.J. Jung, and J.H. Choi Neuropeptides and their receptors in psoriatic skin in relation to pruritus Br J Dermatol 156 2007 1272 1277
29. N. Booken, M. Heck, J.P. Nicolay, C.D. Klemke, S. Goerdt, and J. Utikal Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma Br J Dermatol 164 2011 665 667
30. A. Duval, and L. Dubertret Aprepitant as an antipruritic agent? N Engl J Med 361 2009 1415 1416
31. G. Yosipovitch, and A. Fleischer Itch associated with skin disease: advances in pathophysiology and emerging therapies Am J Clin Dermatol 4 2003 617 622
32. T. Andoh, T. Nagasawa, M. Satoh, and Y. Kuraishi Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice J Pharmacol Exp Ther 286 1998 1140 1145
33. S. Stander, D. Siepmann, I. Herrgott, C. Sunderkotter, and T.A. Luger Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy PLoS One 5 2010 e10968
34. T. Yamamoto, I. Katayama, and K. Nishioka Role of mast cell and stem cell factor in hyperpigmented mycosis fungoides Blood 90 1997 1338 1340
35. U. Meyer-Hoffert Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases Arch Immunol Ther Exp (Warsz) 57 2009 345 354
36. A. Rattenholl, and M. Steinhoff Proteinase-activated receptor-2 in the skin: receptor expression, activation and function during health and disease Drug News Perspect 21 2008 369 381
37. Y.G. Sun, and Z.F. Chen A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord Nature 448 2007 700 703
38. Y.G. Sun, Z.Q. Zhao, X.L. Meng, J. Yin, X.Y. Liu, and Z.F. Chen Cellular basis of itch sensation Science 325 2009 1531 1534
39. G. Yosipovitch, A. Dawn, and M. Greaves Pathophysiology and clinical aspects of pruritus: Introduction T.B. Fitzpatrick, K. Wolff, L. Goldsmith, Fitzpatrick's dermatology in general medicine 7th ed. 2008 McGraw-Hill Medical New York
40. N.Q. Phan, J.D. Bernhard, T.A. Luger, and S. Stander Antipruritic treatment with systemic mu-opioid receptor antagonists: a review J Am Acad Dermatol 63 2010 680 688
41. J.R. Sullivan, and A. Watson Naltrexone: a case report of pruritus from an antipruritic Australas J Dermatol 38 1997 196 198
42. A.G. Dawn, and G. Yosipovitch Butorphanol for treatment of intractable pruritus J Am Acad Dermatol 54 2006 527 531
43. B.D. Smith, and L.D. Wilson Cutaneous lymphoma Curr Probl Cancer 32 2008 43 87
44. J.J. Herrmann, H.H. Roenigk Jr., A. Hurria, T.M. Kuzel, E. Samuelson, and A.W. Rademaker Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up J Am Acad Dermatol 33 1995 234 242
45. A. Hofer, L. Cerroni, H. Kerl, and P. Wolf Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides Arch Dermatol 135 1999 1377 1380
46. D.L. Ramsay, K.M. Lish, C.B. Yalowitz, and N.A. Soter Ultraviolet-B phototherapy for early-stage cutaneous T-cell lymphoma Arch Dermatol 128 1992 931 933
47. J. Krutmann, and A. Morita Mechanisms of ultraviolet (UV) B and UVA phototherapy J Investig Dermatol Symp Proc 4 1999 70 72
48. J.G. Krueger, J.T. Wolfe, R.T. Nabeya, V.P. Vallat, P. Gilleaudeau, and N.S. Heftler Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells J Exp Med 182 1995 2057 2068
49. E.K. Yoo, A.H. Rook, R. Elenitsas, F.P. Gasparro, and B.R. Vowels Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action J Invest Dermatol 107 1996 235 242
50. J. Krutmann, A. Kock, E. Schauer, F. Parlow, A. Moller, and A. Kapp Tumor necrosis factor beta and ultraviolet radiation are potent regulators of human keratinocyte ICAM-1 expression J Invest Dermatol 95 1990 127 131
51. J. Krutmann, and U. Trefzer Modulation of the expression of intercellular adhesion molecule-1 (ICAM-1) in human keratinocytes by ultraviolet (UV) radiation Springer Semin Immunopathol 13 1992 333 344
52. D.A. Norris, M.B. Lyons, M.H. Middleton, J.J. Yohn, and M. Kashihara-Sawami Ultraviolet radiation can either suppress or induce expression of intercellular adhesion molecule 1 (ICAM-1) on the surface of cultured human keratinocytes J Invest Dermatol 95 1990 132 138
53. Y. Tokura, N. Seo, H. Yagi, H. Wakita, S. Moriwaki, and F. Furukawa Treatment of T lymphocytes with 8-methoxypsoralen plus ultraviolet A induces transient but biologically active Th1-skewing cytokine production J Invest Dermatol 113 1999 202 208
54. N. Brink, M. Szamel, A.R. Young, K.P. Wittern, and J. Bergemann Comparative quantification of IL-1beta, IL-10, IL-10r, TNFalpha and IL-7 mRNA levels in UV-irradiated human skin in vivo Inflamm Res 49 2000 290 296
55. P.H. Clingen, M. Berneburg, C. Petit-Frere, A. Woollons, J.E. Lowe, and C.F. Arlett Contrasting effects of an ultraviolet B and an ultraviolet A tanning lamp on interleukin-6, tumor necrosis factor-alpha and intercellular adhesion molecule-1 expression Br J Dermatol 145 2001 54 62
56. A. Kock, T. Schwarz, R. Kirnbauer, A. Urbanski, P. Perry, and J.C. Ansel Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light J Exp Med 172 1990 1609 1614
57. A. Takashima, and P.R. Bergstresser Impact of UVB radiation on the epidermal cytokine network Photochem Photobiol 63 1996 397 400
58. D. Yarosh, D. Both, J. Kibitel, C. Anderson, C. Elmets, and D. Brash Regulation of TNFalpha production and release in human and mouse keratinocytes and mouse skin after UV-B irradiation Photodermatol Photoimmunol Photomed 16 2000 263 270
59. R. Knobler, M.L. Barr, D.R. Couriel, J.L. Ferrara, L.E. French, and P. Jaksch Extracorporeal photopheresis: past, present, and future J Am Acad Dermatol 61 2009 652 665
60. J.A. Zic The treatment of cutaneous T-cell lymphoma with photopheresis Dermatol Ther 16 2003 337 346
61. J. Bladon, and P.C. Taylor Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients Br J Haematol 107 1999 707 711
62. E.K. Yoo, M. Cassin, S.R. Lessin, and A.H. Rook Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity J Am Acad Dermatol 45 2001 208 216
63. M. Di Renzo, P. Rubegni, G. De Aloe, L. Paulesu, A.L. Pasqui, and L. Andreassi Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma Immunology 92 1997 99 103
64. G. Klosner, F. Trautinger, R. Knobler, and P. Neuner Treatment of peripheral blood mononuclear cells with 8-methoxypsoralen plus ultraviolet A radiation induces a shift in cytokine expression from a Th1 to a Th2 response J Invest Dermatol 116 2001 459 462
65. D.J. Hanlon, C.L. Berger, and R.L. Edelson Photoactivated 8-methoxypsoralen treatment causes a peptide-dependent increase in antigen display by transformed lymphocytes Int J Cancer 78 1998 70 75
66. A.C. Moor, I.M. Schmitt, G.M. Beijersbergen van Henegouwen, S. Chimenti, R.L. Edelson, and F.P. Gasparro Treatment with 8-MOP and UVA enhances MHC class I synthesis in RMA cells: preliminary results J Photochem Photobiol B 29 1995 193 198
67. M. Bellone, G. Iezzi, P. Rovere, G. Galati, A. Ronchetti, and M.P. Protti Processing of engulfed apoptotic bodies yields T cell epitopes J Immunol 159 1997 5391 5399
68. C. Berger, K. Hoffmann, J.G. Vasquez, S. Mane, J. Lewis, and R. Filler Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy Blood 116 2010 4838 4847
69. E.A. Olsen, Y.H. Kim, T.M. Kuzel, T.R. Pacheco, F.M. Foss, and S. Parker Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma J Clin Oncol 25 2007 3109 3115
70. J. Lundin, H. Hagberg, R. Repp, E. Cavallin-Stahl, S. Freden, and G. Juliusson Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sézary syndrome Blood 101 2003 4267 4272
71. M.F. Demierre, and J. Taverna Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma J Am Acad Dermatol 55 2006 543 544
72. M.J. Field, P.J. Cox, E. Stott, H. Melrose, J. Offord, and T.Z. Su Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin Proc Natl Acad Sci U S A 103 2006 17537 17542
73. S.A. Anttila, and E.V. Leinonen A review of the pharmacological and clinical profile of mirtazapine CNS Drug Rev 7 2001 249 264
74. J.L. Hundley, and G. Yosipovitch Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study J Am Acad Dermatol 50 2004 889 891
75. L. Brightman, and M.F. Demierre Thalidomide in mycosis fungoides J Am Acad Dermatol 52 2005 1100 1101
76. M. Mettang, and E. Weisshaar Pruritus: control of itch in patients undergoing dialysis Skin Therapy Lett 15 2010 1 5
77. F. Goncalves Thalidomide for the control of severe paraneoplastic pruritus associated with Hodgkin's disease Am J Hosp Palliat Care 27 2010 486 487
78. + subset J Exp Med 187 1998 1885 1892
79. F.E. Davies, N. Raje, T. Hideshima, S. Lentzsch, G. Young, and Y.T. Tai Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma Blood 98 2001 210 216
80. L.G. Corral, P.A. Haslett, G.W. Muller, R. Chen, L.M. Wong, and C.J. Ocampo Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha J Immunol 163 1999 380 386
81. M. Kimmel, D.M. Alscher, R. Dunst, N. Braun, C. Machleidt, and T. Kiefer The role of micro-inflammation in the pathogenesis of uremic pruritus in hemodialysis patients Nephrol Dial Transplant 21 2006 749 755
82. K. Dredge, J.B. Marriott, S.M. Todryk, G.W. Muller, R. Chen, and D.I. Stirling Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity J Immunol 168 2002 4914 4919
83. A. Verbon, N.P. Juffermans, P. Speelman, S.J. van Deventer, I.J. ten Berge, and H.J. Guchelaar A single oral dose of thalidomide enhances the capacity of lymphocytes to secrete gamma interferon in healthy humans Antimicrob Agents Chemother 44 2000 2286 2290